Skip to content

Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity

Effect of Intense Pulse Light (IPL) Treatment on Tear Film Osmolarity in Dry Eye Disease (DED) With Meibomian Gland Dysfunction (MGD).

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02992535
Enrollment
60
Registered
2016-12-14
Start date
2017-01-31
Completion date
2017-06-30
Last updated
2016-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

Evaluate changes in tear film osmolarity and other DED signs/symptoms following treatment with IPL.

Detailed description

Prospective study design among subjects with MGD and qualifying for IPL therapy. Study testing done at baseline visit when subjects are scheduled for IPL therapy. Measurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4). Subjects willing to come for follow up visits as scheduled and may not have instilled any artificial tears 2 hours prior to study measurements. No history of ocular infection or corneal degeneration/dystrophy No history of corneal refractive surgery and/or change in ocular medications in the last 2 months

Interventions

DEVICEIntense Pulse Light Energy delivery (IPL)

Sponsors

Carones Ophthalmology Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Dry eye * MGD

Exclusion criteria

* No history of ocular infection or corneal degeneration/dystrophy * No history of corneal refractive surgery * No change in ocular medications in the last 2 months

Design outcomes

Primary

MeasureTime frame
Tear film osmolarity changeMeasurements will be made on day 15 (prior to second IPL sitting), Day 45 (prior to third IPL setting), Day 75 (fourth IPL setting) and Day 105 as needed (30 days after IPL setting 4).

Contacts

Primary ContactFrancesco Carones, MD
fcarones@carones.com+390276318174

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026